2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one

C155H138F4N42O8 — CID 160714189

IUPAC2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one
SMILESCC(=O)N1CCC(n2ccnc2-c2cccc(-n3ncc4ccc(-n5cnc(C6CC6)c5)cc4c3=O)n2)C1.CC(C)n1ccnc1-c1cccc(-c2coc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(C)n1ccnc1-c1cccc(-n2cnc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(C)n1ccnc1-c1cccc(-n2ncc3cc(F)c(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(n1ccnc1-c1cccc(-n2ncc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1)C(F)(F)F.O=c1c2cc(-n3cnc(C4CC4)c3)ccc2cnn1-c1cccc(-c2nccn2C2CCNC2)n1
InChIInChI=1S/C28H26N8O2.C26H24N8O.C26H23N5O2.C25H20F3N7O.C25H22FN7O.C25H23N7O/c1-18(37)33-11-9-22(15-33)35-12-10-29-27(35)24-3-2-4-26(32-24)36-28(38)23-13-21(8-7-20(23)14-31-36)34-16-25(30-17-34)19-5-6-19;35-26-21-12-19(32-15-23(29-16-32)17-4-5-17)7-6-18(21)13-30-34(26)24-3-1-2-22(31-24)25-28-10-11-33(25)20-8-9-27-14-20;1-16(2)31-11-10-27-26(31)22-5-3-4-21(29-22)20-14-33-24-9-8-18(12-19(24)25(20)32)30-13-23(28-15-30)17-6-7-17;1-15(25(26,27)28)34-10-9-29-23(34)20-3-2-4-22(32-20)35-24(36)19-11-18(8-7-17(19)12-31-35)33-13-21(30-14-33)16-5-6-16;1-15(2)32-9-8-27-24(32)20-4-3-5-23(30-20)33-25(34)18-11-22(19(26)10-17(18)12-29-33)31-13-21(28-14-31)16-6-7-16;1-16(2)31-11-10-26-24(31)21-4-3-5-23(29-21)32-15-28-20-9-8-18(12-19(20)25(32)33)30-13-22(27-14-30)17-6-7-17/h2-4,7-8,10,12-14,16-17,19,22H,5-6,9,11,15H2,1H3;1-3,6-7,10-13,15-17,20,27H,4-5,8-9,14H2;3-5,8-17H,6-7H2,1-2H3;2-4,7-16H,5-6H2,1H3;3-5,8-16H,6-7H2,1-2H3;3-5,8-17H,6-7H2,1-2H3
InChIKeyRSGGWBGVBBTXIM-UHFFFAOYSA-N
MW2793.09 g/mol
LogP25.65
Rot. Bonds30

About 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one

2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one (PubChem CID 160714189) has the molecular formula C155H138F4N42O8 and a molecular weight of 2793.09 g/mol. Its IUPAC name is 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one.

Molecular Properties

Compound Name2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one
PubChem CID160714189
Molecular FormulaC155H138F4N42O8
Molecular Weight2793.09 g/mol
Exact Mass2791.16
IUPAC Name2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one
SMILESCC(=O)N1CCC(n2ccnc2-c2cccc(-n3ncc4ccc(-n5cnc(C6CC6)c5)cc4c3=O)n2)C1.CC(C)n1ccnc1-c1cccc(-c2coc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(C)n1ccnc1-c1cccc(-n2cnc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(C)n1ccnc1-c1cccc(-n2ncc3cc(F)c(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(n1ccnc1-c1cccc(-n2ncc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1)C(F)(F)F.O=c1c2cc(-n3cnc(C4CC4)c3)ccc2cnn1-c1cccc(-c2nccn2C2CCNC2)n1
InChIInChI=1S/C28H26N8O2.C26H24N8O.C26H23N5O2.C25H20F3N7O.C25H22FN7O.C25H23N7O/c1-18(37)33-11-9-22(15-33)35-12-10-29-27(35)24-3-2-4-26(32-24)36-28(38)23-13-21(8-7-20(23)14-31-36)34-16-25(30-17-34)19-5-6-19;35-26-21-12-19(32-15-23(29-16-32)17-4-5-17)7-6-18(21)13-30-34(26)24-3-1-2-22(31-24)25-28-10-11-33(25)20-8-9-27-14-20;1-16(2)31-11-10-27-26(31)22-5-3-4-21(29-22)20-14-33-24-9-8-18(12-19(24)25(20)32)30-13-23(28-15-30)17-6-7-17;1-15(25(26,27)28)34-10-9-29-23(34)20-3-2-4-22(32-20)35-24(36)19-11-18(8-7-17(19)12-31-35)33-13-21(30-14-33)16-5-6-16;1-15(2)32-9-8-27-24(32)20-4-3-5-23(30-20)33-25(34)18-11-22(19(26)10-17(18)12-29-33)31-13-21(28-14-31)16-6-7-16;1-16(2)31-11-10-26-24(31)21-4-3-5-23(29-21)32-15-28-20-9-8-18(12-19(20)25(32)33)30-13-22(27-14-30)17-6-7-17/h2-4,7-8,10,12-14,16-17,19,22H,5-6,9,11,15H2,1H3;1-3,6-7,10-13,15-17,20,27H,4-5,8-9,14H2;3-5,8-17H,6-7H2,1-2H3;2-4,7-16H,5-6H2,1H3;3-5,8-16H,6-7H2,1-2H3;3-5,8-17H,6-7H2,1-2H3
InChIKeyRSGGWBGVBBTXIM-UHFFFAOYSA-N
XLogP25.65
TPSA528.18 Ų
H-Bond Donors1
H-Bond Acceptors49
Rotatable Bonds30
Heavy Atoms209
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002793.09
LogP ≤ 525.65
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1049

Analyze 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one?
The IUPAC name of 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one (CID 160714189) is 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one.
What is the SMILES notation for 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one?
The canonical SMILES for 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one is CC(=O)N1CCC(n2ccnc2-c2cccc(-n3ncc4ccc(-n5cnc(C6CC6)c5)cc4c3=O)n2)C1.CC(C)n1ccnc1-c1cccc(-c2coc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(C)n1ccnc1-c1cccc(-n2cnc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(C)n1ccnc1-c1cccc(-n2ncc3cc(F)c(-n4cnc(C5CC5)c4)cc3c2=O)n1.CC(n1ccnc1-c1cccc(-n2ncc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)n1)C(F)(F)F.O=c1c2cc(-n3cnc(C4CC4)c3)ccc2cnn1-c1cccc(-c2nccn2C2CCNC2)n1.
What is the InChIKey of 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one?
The InChIKey is RSGGWBGVBBTXIM-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26N8O2.C26H24N8O.C26H23N5O2.C25H20F3N7O.C25H22FN7O.C25H23N7O/c1-18(37)33-11-9-22(15-33)35-12-10-29-27(35)24-3-2-4-26(32-24)36-28(38)23-13-21(8-7-20(23)14-31-36)34-16-25(30-17-34)19-5-6-19;35-26-21-12-19(32-15-23(29-16-32)17-4-5-17)7-6-18(21)13-30-34(26)24-3-1-2-22(31-24)25-28-10-11-33(25)20-8-9-27-14-20;1-16(2)31-11-10-27-26(31)22-5-3-4-21(29-22)20-14-33-24-9-8-18(12-19(24)25(20)32)30-13-23(28-15-30)17-6-7-17;1-15(25(26,27)28)34-10-9-29-23(34)20-3-2-4-22(32-20)35-24(36)19-11-18(8-7-17(19)12-31-35)33-13-21(30-14-33)16-5-6-16;1-15(2)32-9-8-27-24(32)20-4-3-5-23(30-20)33-25(34)18-11-22(19(26)10-17(18)12-29-33)31-13-21(28-14-31)16-6-7-16;1-16(2)31-11-10-26-24(31)21-4-3-5-23(29-21)32-15-28-20-9-8-18(12-19(20)25(32)33)30-13-22(27-14-30)17-6-7-17/h2-4,7-8,10,12-14,16-17,19,22H,5-6,9,11,15H2,1H3;1-3,6-7,10-13,15-17,20,27H,4-5,8-9,14H2;3-5,8-17H,6-7H2,1-2H3;2-4,7-16H,5-6H2,1H3;3-5,8-16H,6-7H2,1-2H3;3-5,8-17H,6-7H2,1-2H3.
What are the key properties of 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one?
2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one has a molecular weight of 2793.09 g/mol, XLogP of 25.65, 30 rotatable bonds, 1 hydrogen bond donors, and 49 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-[1-(1-acetylpyrrolidin-3-yl)imidazol-2-yl]-2-pyridinyl]-7-(4-cyclopropylimidazol-1-yl)phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-6-fluoro-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]chromen-4-one;6-(4-cyclopropylimidazol-1-yl)-3-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]quinazolin-4-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-(1-pyrrolidin-3-ylimidazol-2-yl)-2-pyridinyl]phthalazin-1-one;7-(4-cyclopropylimidazol-1-yl)-2-[6-[1-(1,1,1-trifluoropropan-2-yl)imidazol-2-yl]-2-pyridinyl]phthalazin-1-one is sourced from PubChem (CID 160714189), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).